Both CD15 and CD30 were positive in 12 (80%) of 15 cases assessed, and they were both negative in the case of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) and the case of unclassifiable HL. This evidence concerns the gene FUT4 and Hodgkins lymphoma.